• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • Cisema Webinar with US’s AdvaMed: Opportunities and Regulatory Implications in China’s Digital Healthcare Economy

Cisema Webinar with US’s AdvaMed: Opportunities and Regulatory Implications in China’s Digital Healthcare Economy

Friday, 23 April 2021 / Published in News, Webinars

Cisema Webinar with US’s AdvaMed: Opportunities and Regulatory Implications in China’s Digital Healthcare Economy

On May 25, 2021, Cisema and Advamed will cohost a webinar on China’s digital healthcare economy and relevant regulatory framework.

Mr. Hamish King, Chief Operating Officer of Cisema, will lead the discussion to present on the market opportunities and regulatory implications of the fast-growing digital healthcare sector in China. Covid-19 has only served to further accelerate favorable market tailwinds. Telehealth, AI and other key digital health trends in China will be discussed, and the regulatory framework analyzed.

Cisema Webinar: Opportunities and Regulatory Implications in China’s Digital Healthcare Economy

Date: May 25, 2021

Time: 11:00 PM – 12:00 PM (HKT)

Registration Link: TBA

Agenda topics will include:

1.     Digital Healthcare sector in China and recent updates

2.     Regulatory pathways for medical devices and IVDs with the China National Medical Products Administration (NMPA, formerly CFDA)

3.     Cyber security

4.     SaMD registration in China

5.     Alternative regulatory pathways

6.     Q&A

Be sure to stay till the end where our Cisema’s experts will answer your questions that could help equip you to access China’s digital health market.

What you can read next

UDI Database of NMPA: Understand It Within 6 Minutes
Health Food Raw Materials and Functions
China medical device mandatory standards list
China medical device mandatory standards list released in November 2022

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.